{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:07:06Z","timestamp":1790348826857,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jiac.2026.103048","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:24:07Z","timestamp":1786029847000},"page":"103048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Macrolide resistance rate and antimicrobial selection in pediatric Mycoplasma pneumoniae infection during 2024"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5312-4755","authenticated-orcid":false,"given":"Shiho","family":"Iwase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichiro","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9749-565X","authenticated-orcid":false,"given":"Tomoki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2310-3363","authenticated-orcid":false,"given":"Shoko","family":"Ozeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naozumi","family":"Fujishiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohide","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0437-3295","authenticated-orcid":false,"given":"Takako","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9568-5900","authenticated-orcid":false,"given":"Yuka","family":"Torii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jiac.2026.103048_bib2","first-page":"1","article-title":"Editorial board, Chinese journal of pediatrics. Evidence\u2010based guideline for the diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children (2023)","volume":"9","year":"2025","journal-title":"Pediatr Investig"},{"issue":"10","key":"10.1016\/j.jiac.2026.103048_bib3","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.3201\/eid2310.170106","article-title":"Macrolide-resistant Mycoplasma pneumoniae infection, Japan, 2008\u20132015","volume":"23","author":"Tanaka","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2026.103048_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1202357","article-title":"Genotyping of Mycoplasma pneumoniae strains isolated in Japan during 2019 and 2020: spread of p1 gene type 2c and 2j variant strains","volume":"14","author":"Kenri","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jiac.2026.103048_bib5","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268824000323","article-title":"Macrolide resistance of Mycoplasma pneumoniae in several regions of China from 2013 to 2019","volume":"152","author":"Jiang","year":"2024","journal-title":"Epidemiol Infect"},{"issue":"12","key":"10.1016\/j.jiac.2026.103048_bib6","doi-asserted-by":"crossref","first-page":"e446","DOI":"10.1097\/INF.0000000000005019","article-title":"Recent global trends of macrolide-resistant Mycoplasma pneumoniae : why has the macrolide-resistant rate decreased in Japan?","volume":"44","author":"Ouchi","year":"2025","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.jiac.2026.103048_bib7","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1128\/AAC.00048-13","article-title":"Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients","volume":"57","author":"Kawai","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.jiac.2026.103048_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173635","article-title":"Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients","volume":"12","author":"Ishiguro","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2026.103048_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/microorganisms13102243","article-title":"Macrolide-resistant Mycoplasma pneumoniae among Japanese children from 2008 to 2024","volume":"13","author":"Oishi","year":"2025","journal-title":"Microorganisms"},{"issue":"10","key":"10.1016\/j.jiac.2026.103048_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258694","article-title":"Point-of-care molecular diagnosis of Mycoplasma pneumoniae including macrolide sensitivity using quenching probe polymerase chain reaction","volume":"16","author":"Ishiguro","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2026.103048_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fcimb.2020.00385","article-title":"Periodic genotype shifts in clinically prevalent Mycoplasma pneumoniae strains in Japan","volume":"10","author":"Kenri","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jiac.2026.103048_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13756-019-0469-7","article-title":"Antimicrobial susceptibility and genotyping of Mycoplasma pneumoniae isolates in Beijing, China, from 2014 to 2016","volume":"8","author":"Zhao","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.jiac.2026.103048_bib14","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fmicb.2016.00974","article-title":"Mycoplasma pneumoniae: current knowledge on macrolide resistance and treatment","volume":"7","author":"Pereyre","year":"2016","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.jiac.2026.103048_bib15","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejps.2013.02.019","article-title":"Structure\u2013property relationship for cellular accumulation of macrolones in human polymorphonuclear leukocytes (PMNs)","volume":"49","author":"Muni\u0107 Kos","year":"2013","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"10.1016\/j.jiac.2026.103048_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1198-743X(15)60281-6","article-title":"Comparative pharmacokinetics of macrolide antibiotics and concentrations achieved in polymorphonuclear leukocytes and saliva","volume":"1","author":"Fassbender","year":"1996","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/j.jiac.2026.103048_bib17","first-page":"497","article-title":"Tissue penetration properties of macrolide antibiotics comparative tissue distribution of erythromycin-stearate, clarithromycin, roxithromycin and azithromycin in rats","volume":"52","author":"Yoshida","year":"1999","journal-title":"Jpn J Antibiot"},{"issue":"1","key":"10.1016\/j.jiac.2026.103048_bib18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1164\/ajrccm.156.1.9612065","article-title":"Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells","volume":"156","author":"Takizawa","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jiac.2026.103048_bib19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2567.2011.03408.x","article-title":"Cytoadherence-dependent induction of inflammatory responses by Mycoplasma pneumoniae","volume":"133","author":"Shimizu","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.jiac.2026.103048_bib20","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3389\/fmicb.2018.01682","article-title":"The role of lipoproteins in mycoplasma-mediated immunomodulation","volume":"9","author":"Christodoulides","year":"2018","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.jiac.2026.103048_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146377","article-title":"Role of the mycoplasma pneumoniae\/Interleukin-8\/Neutrophil axis in the pathogenesis of pneumonia","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jiac.2026.103048_bib22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/alr.22656","article-title":"Azithromycin and ciprofloxacin inhibit interleukin-8 secretion without disrupting human sinonasal epithelial integrity in vitro","volume":"11","author":"Lim","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"issue":"12","key":"10.1016\/j.jiac.2026.103048_bib23","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/cid\/cis784","article-title":"Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children","volume":"55","author":"Okada","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jiac.2026.103048_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2125.1991.tb03920.x","article-title":"Penetration of minocycline into lung tissues","volume":"32","author":"Naline","year":"1991","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.jiac.2026.103048_bib25","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s10156-011-0235-0","article-title":"Two unexpected phenomena in macrolide-resistant Mycoplasma pneumoniae infection in Japan and the unique biological characteristics of Mycoplasma pneumoniae","volume":"17","author":"Narita","year":"2011","journal-title":"J Infect Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26001467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26001467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:19:21Z","timestamp":1788527961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X26001467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1341321X26001467"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2026.103048","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrolide resistance rate and antimicrobial selection in pediatric Mycoplasma pneumoniae infection during 2024","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2026.103048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103048"}}